United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $361.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $111.9M | 30.9% |
| Other Investing | $38.6M | 10.7% |
| Stock Repurchases | $173.2M | 47.9% |
| Working Capital | $38.1M | 10.5% |
| Net Cash Flow | $0 | 0.0% |